Profile data is unavailable for this security.
About the company
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. is a China-based company principally engaged in the research, development, manufacture and distribution of Chinese patent medicines. The Company’s main products are compound traditional Chinese medicines, including cerecarton capsules,wenxin granules, as well as danhong injections, among others. Its products are mainly applied to the fields of cardio-cerebrovascular diseases and gynecological diseases. The Company distributes its products within domestic market and to overseas markets, with North China, East China and Central China as its major markets.
- Revenue in CNY (TTM)11.72bn
- Net income in CNY-195.75m
- Incorporated2001
- Employees8.31k
- LocationShandong Buchang Pharmaceuticals Co LtdNo. 369Zhonghua West Road, Mudan DistrictHEZE 274000ChinaCHN
- Phone+86 5 305299167
- Fax+86 5 305299286
- Websitehttp://www.buchang.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai Shyndec Pharmaceutical Co Ltd | 11.59bn | 1.07bn | 13.63bn | 11.61k | 12.79 | 1.05 | -- | 1.18 | 0.7945 | 0.7945 | 8.64 | 9.67 | 0.5953 | 3.17 | 6.50 | 998,061.50 | 6.87 | 4.85 | 10.06 | 8.17 | 37.32 | 43.00 | 11.54 | 7.03 | 1.97 | -- | 0.104 | 17.52 | -6.86 | 1.29 | 10.21 | -0.3897 | -2.21 | 0.00 |
| Tonghua Dongbao Pharmaceutical Co Ltd | 2.45bn | 452.54m | 14.27bn | 3.20k | 34.27 | 2.20 | -- | 5.83 | 0.2101 | 0.2101 | 1.25 | 3.28 | 0.3527 | 0.697 | 4.25 | 766,304.10 | 6.51 | 18.68 | 6.85 | 19.68 | 78.80 | 78.73 | 18.47 | 39.20 | 3.07 | -- | 0.0524 | 41.73 | 10.69 | 2.69 | -26.17 | 6.85 | -14.75 | 4.56 |
| Zhejiang Medicine Co., Ltd. | 8.26bn | 472.71m | 14.42bn | 6.23k | 29.90 | 1.45 | -- | 1.75 | 0.5017 | 0.5017 | 8.72 | 10.34 | 0.6455 | 2.81 | 6.18 | 1,326,750.00 | 2.70 | 4.32 | 3.41 | 5.68 | 32.28 | 36.57 | 4.18 | 6.28 | 1.77 | 3.64 | 0.0755 | 58.72 | -3.96 | 2.59 | -20.37 | 3.34 | 12.65 | 0.00 |
| Suzhou Zelgen Biopharmaceuticals Co Ltd | 407.21m | -230.89m | 15.59bn | 867.00 | -- | 9.95 | -- | 38.28 | -0.8669 | -0.8669 | 1.53 | 5.92 | 0.1364 | 0.2484 | 3.38 | 469,674.00 | -8.44 | -27.13 | -13.16 | -39.20 | 92.31 | 92.75 | -61.85 | -220.71 | 2.19 | -- | 0.3791 | -- | 27.83 | 211.81 | 39.08 | -- | 41.38 | -- |
| Shandong Buchang Pharmaceuticals Co Ltd | 11.72bn | -195.75m | 16.60bn | 8.31k | -- | 1.44 | -- | 1.42 | -0.177 | -0.177 | 10.60 | 10.46 | 0.5416 | 1.04 | 9.76 | 1,410,074.00 | -1.62 | 3.26 | -2.37 | 4.72 | 61.16 | 74.71 | -2.99 | 4.85 | 0.5242 | 0.7126 | 0.2763 | 121.01 | -11.41 | -0.6219 | 120.85 | -29.93 | -16.56 | -36.72 |
| Joincare Pharmaceutical Group Ind. Co. | 16.16bn | 1.40bn | 18.12bn | 14.37k | 12.68 | 1.27 | -- | 1.12 | 0.7626 | 0.7626 | 8.76 | 7.64 | 0.4444 | 2.29 | 5.29 | 1,125,043.00 | 8.03 | 8.46 | 16.91 | 18.84 | 61.38 | 62.72 | 18.07 | 17.00 | 1.89 | -- | 0.2222 | 28.86 | -2.90 | 8.24 | -3.99 | 15.58 | 11.53 | 2.38 |
Data as of Sep 13 2024. Currency figures normalised to Shandong Buchang Pharmaceuticals Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
2.49%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Yinhua Fund Management Co., Ltd.as of 31 Dec 2023 | 5.13m | 0.46% |
| China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 4.34m | 0.39% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 3.87m | 0.35% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 3.24m | 0.29% |
| China Asset Management Co., Ltd.as of 31 Dec 2023 | 2.94m | 0.27% |
| The Vanguard Group, Inc.as of 31 Jul 2024 | 2.61m | 0.24% |
| Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 1.69m | 0.15% |
| Wanjia Asset Management Co., Ltd.as of 31 Dec 2023 | 1.50m | 0.14% |
| Western Leadbank Fund Management Co., Ltdas of 31 Dec 2023 | 1.23m | 0.11% |
| Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 992.93k | 0.09% |
More ▼
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.
